When wedge resection is good enough: Survival outcomes and nodal involvement of ground-glass–dominant stage IA non–small cell lung cancer

IF 1.9
JTCVS open Pub Date : 2026-02-01 Epub Date: 2025-12-06 DOI:10.1016/j.xjon.2025.101549
Naoyuki Oka MD , Masaya Yotsukura MD , Yukihiro Yoshida MD , Yasushi Yatabe MD , Shun-ichi Watanabe MD
{"title":"When wedge resection is good enough: Survival outcomes and nodal involvement of ground-glass–dominant stage IA non–small cell lung cancer","authors":"Naoyuki Oka MD ,&nbsp;Masaya Yotsukura MD ,&nbsp;Yukihiro Yoshida MD ,&nbsp;Yasushi Yatabe MD ,&nbsp;Shun-ichi Watanabe MD","doi":"10.1016/j.xjon.2025.101549","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Whether the indications for wedge resection can be extended to early-stage non–small cell lung cancer (NSCLC) remains unclear. We investigated the survival outcomes and nodal involvement of ground-glass-opacity–dominant stage IA NSCLC undergoing wedge resection, segmentectomy, or lobectomy.</div></div><div><h3>Methods</h3><div>We retrospectively investigated the prognostic and clinicopathological outcomes of patients who underwent lung resection for ground-glass-opacity–dominant clinical stage IA (diameter ≤3 cm; consolidation-to-tumor ratio ≤0.5) NSCLC between 2017 and 2022. Patients with tumors ≤2 cm and consolidation-to-tumor ratio ≤0.25 were excluded. Propensity score matching was performed to equalize the preoperative characteristics of patients undergoing wedge resection and segmentectomy. Overall and relapse-free survival rates were estimated, and differences were compared.</div></div><div><h3>Results</h3><div>Of the 398 patients who met the inclusion criteria, 77, 258, and 63 underwent lobectomy, segmentectomy, and wedge resection, respectively. Two (0.5%) patients experienced disease recurrence, and 6 (1.5%) patients died; however, no lung cancer-related deaths were observed. Two patients developed locoregional recurrence, all of which were nodal. No patients had pN1/2 disease. The 5-year overall and relapse-free survival rates were 97.6% and 96.4%, respectively. Relapse-free survival did not differ significantly according to the extent of lung resection (91.7%, 97.7%, and 100%; <em>P</em> = .146). Even after propensity score matching, overall and relapse-free survival did not differ significantly between wedge resection and segmentectomy.</div></div><div><h3>Conclusions</h3><div>Patients with ground-glass-opacity–dominant clinical stage IA NSCLC showed an excellent prognosis, with no survival differences between procedures. In those patients, wedge resection without nodal dissection may be oncologically equivalent to anatomic resection.</div></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"29 ","pages":"Article 101549"},"PeriodicalIF":1.9000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTCVS open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666273625004802","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Whether the indications for wedge resection can be extended to early-stage non–small cell lung cancer (NSCLC) remains unclear. We investigated the survival outcomes and nodal involvement of ground-glass-opacity–dominant stage IA NSCLC undergoing wedge resection, segmentectomy, or lobectomy.

Methods

We retrospectively investigated the prognostic and clinicopathological outcomes of patients who underwent lung resection for ground-glass-opacity–dominant clinical stage IA (diameter ≤3 cm; consolidation-to-tumor ratio ≤0.5) NSCLC between 2017 and 2022. Patients with tumors ≤2 cm and consolidation-to-tumor ratio ≤0.25 were excluded. Propensity score matching was performed to equalize the preoperative characteristics of patients undergoing wedge resection and segmentectomy. Overall and relapse-free survival rates were estimated, and differences were compared.

Results

Of the 398 patients who met the inclusion criteria, 77, 258, and 63 underwent lobectomy, segmentectomy, and wedge resection, respectively. Two (0.5%) patients experienced disease recurrence, and 6 (1.5%) patients died; however, no lung cancer-related deaths were observed. Two patients developed locoregional recurrence, all of which were nodal. No patients had pN1/2 disease. The 5-year overall and relapse-free survival rates were 97.6% and 96.4%, respectively. Relapse-free survival did not differ significantly according to the extent of lung resection (91.7%, 97.7%, and 100%; P = .146). Even after propensity score matching, overall and relapse-free survival did not differ significantly between wedge resection and segmentectomy.

Conclusions

Patients with ground-glass-opacity–dominant clinical stage IA NSCLC showed an excellent prognosis, with no survival differences between procedures. In those patients, wedge resection without nodal dissection may be oncologically equivalent to anatomic resection.
当楔形切除术足够好时:磨玻璃显性IA期非小细胞肺癌的生存结局和淋巴结累及
目的楔形切除术的适应症是否可以推广到早期非小细胞肺癌(NSCLC)尚不清楚。我们研究了以磨玻璃混浊为主的IA期NSCLC在楔形切除术、节段切除术或肺叶切除术后的生存结果和淋巴结累及情况。方法回顾性分析2017年至2022年间,以磨玻璃混浊为主的IA期(直径≤3cm,实变-肿瘤比≤0.5)非小细胞肺癌行肺切除术患者的预后和临床病理结果。排除肿瘤≤2 cm,实变-肿瘤比≤0.25的患者。采用倾向评分匹配来平衡楔形切除术和节段切除术患者的术前特征。估计总生存率和无复发生存率,并比较差异。结果在398例符合纳入标准的患者中,分别有77例、258例和63例接受了肺叶切除术、节段切除术和楔形切除术。2例(0.5%)患者复发,6例(1.5%)患者死亡;然而,没有观察到肺癌相关的死亡。2例发生局部复发,均为淋巴结性复发。无pN1/2病变。5年总生存率为97.6%,无复发生存率为96.4%。肺切除程度不同,无复发生存率无显著差异(91.7%、97.7%和100%;P = 0.146)。即使在倾向评分匹配后,楔形切除术和节段切除术的总体生存率和无复发生存率也没有显著差异。结论磨玻璃混浊为主的IA期非小细胞肺癌患者预后良好,不同手术的生存率无差异。在这些患者中,不进行淋巴结清扫的楔形切除可能在肿瘤学上等同于解剖切除。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书